rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Karim Galzahr

Director

Company insider

Files Form 4 as: Director, OS Therapies.

In numbers

Trades disclosed
3
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
21 Oct 2025
Last trade
22 Jan 2026
Last filed
13 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
OSTX OS TherapiesDirector · Biotechnology · last 22 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
22 Jan 2026filed 13 Feb 2026OSTX OS Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
22 Jan 2026filed 13 Feb 2026OSTX OS Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
21 Oct 2025filed 19 Dec 2025OSTX OS Therapiesoption or derivative · BiotechnologySEC FORM 4 Code A—140,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Paul A. RomnessPresident and CEO · President and CEO at OS Therapies, filing Form 4 there in the last year
Olivier Roger JarryDirector · Director at OS Therapies, filing Form 4 there in the last year
John CiccioDirector · Director at OS Therapies, filing Form 4 there in the last year
Robert PetitOfficer · Officer at OS Therapies, filing Form 4 there in the last year
Christopher P. AcevedoChief Financial Officer · Chief Financial Officer at OS Therapies, filing Form 4 there in the last year